Goto, M., Sato, M., & Hirose, T
14.2 Bardet-Biedl Syndrome (Adults and Pediatric Patients Aged 6 Years and Older) Clinical Trial Overview The efficacy of IMCIVREE for weight reduction in adults and pediatric patients aged 6 years and older with obesity and a clinical diagnosis of Bardet-Biedl syndrome (BBS) were assessed in a 66-week clinical trial, which included a 14 week randomized, double-blind, placebo-controlled period and a 52-week open-label period (Trial 2 [ NCT03746522])
Our online semaglutide prescription services make it easier for Dalton residents to receive personalized treatment plans designed to meet their unique health needs and goals
FranznBDuvefeltKJonssonCEngelhardtBOttervaldJWickmanMet al
Easy on the eyes and not cluttered with unnecessary detail, but has an option to add and remove details
Li Q, Guan X, Wu P, et al